Clinical Sciences

Medicine & Life Sciences

1. Cardiovascular Diseases 100%
2. Cardiorespiratory Fitness 97%
3. Radiotherapy 93%
4. Neoplasms 91%
5. Head and Neck Neoplasms 90%
6. Heart Failure 90%
7. Survival 74%
8. Heart 61%
9. Confidence Intervals 56%
10. Breast Neoplasms 53%
11. Population 52%
12. Therapeutics 51%
13. Clinical Trials 49%
14. Mortality 45%
15. Oropharyngeal Neoplasms 45%
16. Cancer Survivors 45%
17. Exercise 43%
18. Neck 43%
19. Cost-Benefit Analysis 41%
20. Blood Pressure 40%
21. Longitudinal Studies 39%
22. Head 39%
23. Hepatocellular Carcinoma 39%
24. Health 38%
25. Meta-Analysis 37%
26. Smoking Cessation 37%
27. Squamous Cell Carcinoma 37%
28. Costs and Cost Analysis 36%
29. Colorectal Neoplasms 36%
30. Randomized Controlled Trials 36%
31. Early Detection of Cancer 36%
32. Statistics 33%
33. Smoking 32%
34. Systematic Reviews 32%
35. Medicare 31%
36. Radiosurgery 30%
37. Left Ventricular Hypertrophy 29%
38. Peripheral Arterial Disease 28%
39. Veterans 28%
40. Cohort Studies 28%
41. Drug Therapy 28%
42. Delivery of Health Care 28%
43. Atherosclerosis 28%
44. Heart Diseases 27%
45. Coronary Vessels 27%
46. Pandemics 27%
47. Deep Learning 27%
48. Stroke 27%
49. Body Mass Index 26%
50. Odds Ratio 26%
51. Natriuretic Peptides 26%
52. Squamous Cell Carcinoma of Head and Neck 25%
53. lonidamine 25%
54. Hispanic Americans 25%
55. Guidelines 25%
56. Bayes Theorem 24%
57. Hypertension 24%
58. Mammography 24%
59. Brain Hypoxia 24%
60. American Heart Association 24%
61. Prostatic Neoplasms 23%
62. Safety 23%
63. Registries 23%
64. Recurrence 23%
65. Heterografts 23%
66. Metabolic Equivalent 22%
67. Adjuvant Chemotherapy 22%
68. Laryngeal Neoplasms 22%
69. Biomarkers 22%
70. Hydroxymethylglutaryl-CoA Reductase Inhibitors 22%
71. Melanoma 22%
72. Neoplasm Metastasis 22%
73. Brain Natriuretic Peptide 22%
74. Middle Aged 21%
75. Growth 21%
76. Non-Small Cell Lung Carcinoma 21%
77. Coronary Disease 21%
78. Radiation 20%
79. Hydroxychloroquine 20%
80. Linear Models 20%
81. Survivorship 20%
82. Datasets 20%
83. Femoral Artery 19%
84. Melphalan 19%
85. Research Personnel 19%
86. Placebos 19%
87. Malignant Mesothelioma 19%
88. Nicotine 19%
89. Myocardial Infarction 18%
90. Smokers 18%
91. Tobacco Products 18%
92. Fibrosis 18%
93. Chemoradiotherapy 18%
94. Ankle Brachial Index 18%
95. Lymph Nodes 18%
96. Logistic Models 17%
97. Health Care Costs 17%
98. Walking 17%
99. Type 2 Diabetes Mellitus 17%
100. Incidence 16%